Skip to content
naulon
Not checkedNot checked for notices yet.

Novel ELISA Based on Purified and Recombinant Antigens from Toxocara Canis Exhibits a High Diagnostic Sensitivity

J. Schaefer, B. Menge, K. Stiba and 4 more

International Journal of Infectious Diseases · 2022

doi:10.1016/j.ijid.2021.12.223 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Purpose: Toxocariasis is a zoonosis that is mainly caused by the dog roundworm Toxocara canis and the cat roundworm T. cati. The prevalence of T. canis-specific antibodies in humans is 2-5% in Germany. Many infections with Toxocara spp. have a subclinical course, but can develop into a severe disease, with visceral, ocular, or neurotoxic manifestations. While first serological antibody detection methods were based on the whole lysate from T. canis larvae, meanwhile Toxocara excretory/secretory (TES) antigens from larvae cultures are used. Here, we evaluated the diagnostic performance of a new ELISA based on a highly purified larval antigen from T. canis and recombinant TES antigen. Methods & Materials: [1] Comparison with an external quality assessment scheme (NEQAS, UK) encompassing 9 positive and 8 negative sera.[2] Agreement study with a commercial Toxocara canis IgG ELISA (based on T. canis antigens; IBL International, Germany) including 117 sera pre-characterised by IBL ELISA.[3] Specificity was evaluated with respect to a control panel containing 586 sera from healthy blood donors, 98 from pregnant women and 197 from children as well as a cross-reactivity panel (135 sera from patients infected with Strongyloides, Schistosoma, Ascaris, Trichinella and other parasitic/bacterial infections). Results: Results obtained with the Anti-Toxocara ELISA were 100% in agreement with the NEQAS target values (sensitivity: 88.9%, specificity: 100%).The agreement between the two methods was substantial (79%, κ=0.57). The EUROIMMUN ELISA found 86 and the IBL ELISA 71 positive samples (negative predictive value=1). The EUROIMMUN ELISA found 23 and the IBL ELISA 41 negative samples. Thirteen discrepant samples were positive in the EUROIMMUN ELISA but negative in the IBL ELISA.The Anti-Toxocara ELISA was reactive in 25.9% of samples in the cross-reactivity panel and in 4.5% of the samples from healthy individuals, yielding a combined specificity of 92.6%. Conclusion: The novel Anti-Toxocara ELISA is a valuable screening test for sensitive serological detection of T. canis infections. Possible past infections or double infections with other parasites should be considered when evaluating the test result. A positive ELISA test result could be confirmed by a corresponding Western blot, which is available from EUROIMMUN.

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.